Consequently, after COVID-19 antigen exposure, this metabolic inflammation may impair macrophage activation, exaggerate pro- inflammatory cytokines/chemokines like TNF-a, IFN-g and alter innate/adaptive immunity (55–58). The gene discussed is IFNG; the disease is COVID-19.